About: BCAL Diagnostics Limited, a biotechnology company, engages in developing a novel blood screening test to support the early diagnosis and monitoring of breast cancer in Australia. It is involved in the development and commercialization of BREASTESTplus; Avantect Pancreatic; Avantect Ovarian; BREASTESTplus 2; BREASTEST Monitor; and Avantect multi-cancer test. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.06 (0.00%)
BDX ASX Bcal Diagnostics Ltd
Bcal Diagnostics Ltd share price
Atividade de preço de BDX
Último preço
$ 0,060
Variação (24h)
0,00 AUD (0%)
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
$ 0,06
Último negócio
20 Nov, 5:00 am GMT+0
Atrasado
20 Nov, 5:00 am GMT+0
BDX price performance
Atrasado
20 Nov, 5:00 am GMT+0
BDX details
quote.marketSignals